The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics
Human norovirus (HuNoV) is the leading cause of acute nonbacterial gastroenteritis. Vaccine design has been confounded by the antigenic diversity of these viruses and a limited understanding of protective immunity. We reviewed 77 articles published since 1988 describing the isolation, function, and...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/11/5/432 |
_version_ | 1818288358265192448 |
---|---|
author | Jessica M. van Loben Sels Kim Y. Green |
author_facet | Jessica M. van Loben Sels Kim Y. Green |
author_sort | Jessica M. van Loben Sels |
collection | DOAJ |
description | Human norovirus (HuNoV) is the leading cause of acute nonbacterial gastroenteritis. Vaccine design has been confounded by the antigenic diversity of these viruses and a limited understanding of protective immunity. We reviewed 77 articles published since 1988 describing the isolation, function, and mapping of 307 unique monoclonal antibodies directed against B cell epitopes of human and murine noroviruses representing diverse Genogroups (G). Of these antibodies, 91, 153, 21, and 42 were reported as GI-specific, GII-specific, MNV GV-specific, and G cross-reactive, respectively. Our goal was to reconstruct the antigenic topology of noroviruses in relationship to mapped epitopes with potential for therapeutic use or inclusion in universal vaccines. Furthermore, we reviewed seven published studies of norovirus T cell epitopes that identified 18 unique peptide sequences with CD4- or CD8-stimulating activity. Both the protruding (P) and shell (S) domains of the major capsid protein VP1 contained B and T cell epitopes, with the majority of neutralizing and HBGA-blocking B cell epitopes mapping in or proximal to the surface-exposed P2 region of the P domain. The majority of broadly reactive B and T cell epitopes mapped to the S and P1 arm of the P domain. Taken together, this atlas of mapped B and T cell epitopes offers insight into the promises and challenges of designing universal vaccines and immunotherapy for the noroviruses. |
first_indexed | 2024-12-13T01:55:07Z |
format | Article |
id | doaj.art-371240e009604999a3cea560b47fb8b8 |
institution | Directory Open Access Journal |
issn | 1999-4915 |
language | English |
last_indexed | 2024-12-13T01:55:07Z |
publishDate | 2019-05-01 |
publisher | MDPI AG |
record_format | Article |
series | Viruses |
spelling | doaj.art-371240e009604999a3cea560b47fb8b82022-12-22T00:03:25ZengMDPI AGViruses1999-49152019-05-0111543210.3390/v11050432v11050432The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and TherapeuticsJessica M. van Loben Sels0Kim Y. Green1Caliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS, Bethesda, MD 20892, USACaliciviruses Section, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, DHHS, Bethesda, MD 20892, USAHuman norovirus (HuNoV) is the leading cause of acute nonbacterial gastroenteritis. Vaccine design has been confounded by the antigenic diversity of these viruses and a limited understanding of protective immunity. We reviewed 77 articles published since 1988 describing the isolation, function, and mapping of 307 unique monoclonal antibodies directed against B cell epitopes of human and murine noroviruses representing diverse Genogroups (G). Of these antibodies, 91, 153, 21, and 42 were reported as GI-specific, GII-specific, MNV GV-specific, and G cross-reactive, respectively. Our goal was to reconstruct the antigenic topology of noroviruses in relationship to mapped epitopes with potential for therapeutic use or inclusion in universal vaccines. Furthermore, we reviewed seven published studies of norovirus T cell epitopes that identified 18 unique peptide sequences with CD4- or CD8-stimulating activity. Both the protruding (P) and shell (S) domains of the major capsid protein VP1 contained B and T cell epitopes, with the majority of neutralizing and HBGA-blocking B cell epitopes mapping in or proximal to the surface-exposed P2 region of the P domain. The majority of broadly reactive B and T cell epitopes mapped to the S and P1 arm of the P domain. Taken together, this atlas of mapped B and T cell epitopes offers insight into the promises and challenges of designing universal vaccines and immunotherapy for the noroviruses.https://www.mdpi.com/1999-4915/11/5/432norovirusadaptive immunitymonoclonal antibodiesepitope mappingT cell epitopesB cell epitopestherapeutic antibodiesnanobodies (VHH)scFvuniversal vaccines |
spellingShingle | Jessica M. van Loben Sels Kim Y. Green The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics Viruses norovirus adaptive immunity monoclonal antibodies epitope mapping T cell epitopes B cell epitopes therapeutic antibodies nanobodies (VHH) scFv universal vaccines |
title | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics |
title_full | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics |
title_fullStr | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics |
title_full_unstemmed | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics |
title_short | The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics |
title_sort | antigenic topology of norovirus as defined by b and t cell epitope mapping implications for universal vaccines and therapeutics |
topic | norovirus adaptive immunity monoclonal antibodies epitope mapping T cell epitopes B cell epitopes therapeutic antibodies nanobodies (VHH) scFv universal vaccines |
url | https://www.mdpi.com/1999-4915/11/5/432 |
work_keys_str_mv | AT jessicamvanlobensels theantigenictopologyofnorovirusasdefinedbybandtcellepitopemappingimplicationsforuniversalvaccinesandtherapeutics AT kimygreen theantigenictopologyofnorovirusasdefinedbybandtcellepitopemappingimplicationsforuniversalvaccinesandtherapeutics AT jessicamvanlobensels antigenictopologyofnorovirusasdefinedbybandtcellepitopemappingimplicationsforuniversalvaccinesandtherapeutics AT kimygreen antigenictopologyofnorovirusasdefinedbybandtcellepitopemappingimplicationsforuniversalvaccinesandtherapeutics |